title: Using dried blood spot sampling to improve data quality and reduce animal use in mouse pharmacokinetic studies.
abstract: Traditional pharmacokinetic analysis in nonclinical studies is based on the concentration of a test compound in plasma and requires approximately 100 to 200 μL blood collected per time point. However, the total blood volume of mice limits the number of samples that can be collected from an individual animal-often to a single collection per mouse-thus necessitating dosing multiple mice to generate a pharmacokinetic profile in a sparse-sampling design. Compared with traditional methods, dried blood spot (DBS) analysis requires smaller volumes of blood (15 to 20 μL), thus supporting serial blood sampling and the generation of a complete pharmacokinetic profile from a single mouse. Here we compare plasma-derived data with DBS-derived data, explain how to adopt DBS sampling to support discovery mouse studies, and describe how to generate pharmacokinetic and pharmacodynamic data from a single mouse. Executing novel study designs that use DBS enhances the ability to identify and streamline better drug candidates during drug discovery. Implementing DBS sampling can reduce the number of mice needed in a drug discovery program. In addition, the simplicity of DBS sampling and the smaller numbers of mice needed translate to decreased study costs. Overall, DBS sampling is consistent with 3Rs principles by achieving reductions in the number of animals used, decreased restraint-associated stress, improved data quality, direct comparison of interanimal variability, and the generation of multiple endpoints from a single study.
authors.affiliation: Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, USA. enaksha@lilly.com.
authors.forename: Enaksha R
authors.initials: ER
authors.lastname: Wickremsinhe
authors.affiliation: Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, USA.
authors.forename: Everett J
authors.initials: EJ
authors.lastname: Perkins
mesh_terms: D035661:Animal Care Committees; D032761:Animal Experimentation / Q000592:standards; D000827:Animal Welfare; D000818:Animals; D000830:Animals, Laboratory; D059788:Dried Blood Spot Testing / Q000662:veterinary*; D051379:Mice / Q000097:blood*; D012107:Research Design
references.citation: Bioanalysis. 2012 Aug;4(16):1989-98
references.pmid: 22946915
references.citation: Bioanalysis. 2012 May;4(9):1077-95
references.pmid: 22612688
references.citation: J Mass Spectrom. 2012 May;47(5):655-67
references.pmid: 22576879
references.citation: Bioanalysis. 2012 Mar;4(6):661-74
references.pmid: 22452257
references.citation: Eur J Drug Metab Pharmacokinet. 2012 Mar;37(1):23-30
references.pmid: 21948266
references.citation: J Pharm Biomed Anal. 2011 Dec 15;56(5):1057-63
references.pmid: 21890296
references.citation: Rapid Commun Mass Spectrom. 2011 Oct 15;25(19):2951-8
references.pmid: 21913274
references.citation: J Pharm Biomed Anal. 2011 Nov 1;56(3):604-8
references.pmid: 21784595
references.citation: Bioanalysis. 2011 Jul;3(14):1635-46
references.pmid: 21756096
references.citation: Bioanalysis. 2010 Nov;2(11):1791-6
references.pmid: 21083484
references.citation: Bioanalysis. 2010 Aug;2(8):1477-88
references.pmid: 21083348
references.citation: Bioanalysis. 2013 Oct;5(20):2547-65
references.pmid: 24138627
references.citation: Bioanalysis. 2013 May;5(9):1131-5
references.pmid: 23641701
references.citation: Bioanalysis. 2013 Mar;5(6):731-8
references.pmid: 23484790
references.citation: Bioanalysis. 2013 Jan;5(2):159-70
references.pmid: 23330559
references.citation: Anal Chem. 2013 Jan 15;85(2):779-89
references.pmid: 23171435
references.citation: Anal Bioanal Chem. 2012 Dec;404(10):3037-48
references.pmid: 23099526
references.citation: Bioanalysis. 2010 Nov;2(11):1783-6
references.pmid: 21083482
references.citation: AAPS J. 2010 Sep;12(3):290-3
references.pmid: 20383669
references.citation: J Chromatogr B Analyt Technol Biomed Life Sci. 2010 Mar 15;878(9-10):769-76
references.pmid: 20153705
references.citation: Biomed Chromatogr. 2010 Jan;24(1):49-65
references.pmid: 20017122
references.citation: Ther Drug Monit. 2009 Jun;31(3):327-36
references.pmid: 19349929
references.citation: Anal Chem. 2009 Feb 15;81(4):1557-63
references.pmid: 19154107
references.citation: J Pharm Biomed Anal. 2007 Jun 28;44(2):342-55
references.pmid: 17360141
references.citation: J Acquir Immune Defic Syndr. 2005 Apr 15;38(5):615-7
references.pmid: 15793374
references.citation: Hum Genet. 1987 Mar;75(3):213-6
references.pmid: 3030923
references.citation: Lancet. 1979 Mar 3;1(8114):472-4
references.pmid: 85057
references.citation: J Chromatogr B Analyt Technol Biomed Life Sci. 2004 Sep 25;809(1):153-8
references.pmid: 15282106
references.citation: J Chromatogr B Biomed Sci Appl. 2001 Apr 15;754(1):245-51
references.pmid: 11318421
references.citation: J Appl Toxicol. 2001 Jan-Feb;21(1):15-23
references.pmid: 11180276